Lyell Immunopharma shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $620k | 278k | 2.23 |
| 2023-12-31 | $526k | 271k | 1.94 |
| 2023-09-30 | $395k | 269k | 1.47 |
| 2023-06-30 | $874k | 275k | 3.18 |
| 2023-03-31 | $642k | 272k | 2.36 |
| 2022-12-31 | $913k | 263k | 3.47 |
| 2022-09-30 | $2.0M | 268k | 7.33 |
| 2022-06-30 | $1.6M | 250k | 6.52 |
| 2022-03-31 | $764k | 151k | 5.05 |
| 2021-12-31 | $180k | 23k | 7.72 |
| 2021-09-30 | $250k | 17k | 14.80 |